Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Garrett

Showing results (281-290 of 330) with videos related to

Pageof 33
Sort By:
Cancer Research|July 29, 2016
Lack of p53 Augments Antitumor Functions in Cytolytic T CellsAnirban Banerjee, Krishnamurthy Thyagarajan, Shilpak Chatterjee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker StudyKala Visvanathan, MaryJo S Fackler, Zhe Zhang, et al.
EMBO Molecular Medicine|November 28, 2012
Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosisSahar A Saddoughi, Salih Gencer, Yuri K Peterson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2012
A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in miceShikhar Mehrotra, Amir A Al-Khami, Jared Klarquist, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 16, 2005
Pharmacologic and toxicologic evaluation of C. novyi-NT sporesLuis A Diaz, Ian Cheong, Catherine A Foss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinomaAndré Lopes Carvalho, Carmen Jeronimo, Michael M Kim, et al.
JCO Precision Oncology|April 30, 2026
Pertuzumab and Trastuzumab in Patients With <i>ERBB2/3</i>-Altered Urothelial or Ovary/Fallopian Tube Cancer: Results From the Targeted Agent and Profiling Utilization Registry StudyJohn K Chan, Michael Rothe, Elizabeth Garrett-Mayer, et al.
JCO Precision Oncology|July 16, 2024
Palbociclib in Patients With Soft Tissue Sarcoma With <i>CDK4</i> Amplifications: Results From the Targeted Agent and Profiling Utilization Registry StudyScott Schuetze, Michael Rothe, Pam K Mangat, et al.
Journal of the National Cancer Institute|December 19, 2018
Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in OncologyBrian P Hobbs, Pedro C Barata, Yada Kanjanapan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 3, 2011
Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozoleTatiana M Prowell, Amanda L Blackford, Celia Byrne, et al.
Pageof 33

Showing results (281-290 of 330) with videos related to

Sort By:
Pageof 33
Cancer Research|July 29, 2016
Lack of p53 Augments Antitumor Functions in Cytolytic T CellsAnirban Banerjee, Krishnamurthy Thyagarajan, Shilpak Chatterjee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2016
Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker StudyKala Visvanathan, MaryJo S Fackler, Zhe Zhang, et al.
EMBO Molecular Medicine|November 28, 2012
Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosisSahar A Saddoughi, Salih Gencer, Yuri K Peterson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2012
A coreceptor-independent transgenic human TCR mediates anti-tumor and anti-self immunity in miceShikhar Mehrotra, Amir A Al-Khami, Jared Klarquist, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 16, 2005
Pharmacologic and toxicologic evaluation of C. novyi-NT sporesLuis A Diaz, Ian Cheong, Catherine A Foss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinomaAndré Lopes Carvalho, Carmen Jeronimo, Michael M Kim, et al.
JCO Precision Oncology|April 30, 2026
Pertuzumab and Trastuzumab in Patients With <i>ERBB2/3</i>-Altered Urothelial or Ovary/Fallopian Tube Cancer: Results From the Targeted Agent and Profiling Utilization Registry StudyJohn K Chan, Michael Rothe, Elizabeth Garrett-Mayer, et al.
JCO Precision Oncology|July 16, 2024
Palbociclib in Patients With Soft Tissue Sarcoma With <i>CDK4</i> Amplifications: Results From the Targeted Agent and Profiling Utilization Registry StudyScott Schuetze, Michael Rothe, Pam K Mangat, et al.
Journal of the National Cancer Institute|December 19, 2018
Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in OncologyBrian P Hobbs, Pedro C Barata, Yada Kanjanapan, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 3, 2011
Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozoleTatiana M Prowell, Amanda L Blackford, Celia Byrne, et al.
Pageof 33